Serina Therapeutics, Inc. Operating Cash Flow
Serina Therapeutics, Inc. (SER) reported Operating Cash Flow of -$11.25 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-13
- Serina Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$6.68M.
- Serina Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$4.57M.
- Serina Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$6.03M.
- Serina Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$3.85M.
- Serina Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2025 was -$17.95M.
- Serina Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2024 was -$17.14M.
- Serina Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2023 was -$2.48M.
- Serina Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2022 was -$5.94M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$6.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$11.25M 10-Q · filed 2026-08-13 | -$17.29M derived: sum of 3 quarters · filed 2026-08-13 | -$21.14M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | -$4.57M 10-Q · filed 2026-05-14 | -$10.60M derived: sum of 2 quarters · filed 2026-05-14 | -$14.45M derived: sum of 3 quarters · filed 2026-05-14 | -$18.20M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | -$6.03M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$9.88M derived: sum of 2 quarters · filed 2026-03-25 | -$13.63M derived: sum of 3 quarters · filed 2026-08-13 | -$17.95M 10-K · filed 2026-03-25 | ||||
| 2025-09-30 | -$3.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$7.60M derived: sum of 2 quarters · filed 2026-08-13 | -$11.92M 10-Q · filed 2025-11-13 | -$16.51M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | -$3.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$8.07M 10-Q · filed 2026-08-13 | -$12.66M derived: sum of 3 quarters · filed 2026-08-13 | -$15.62M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | -$4.32M 10-Q · filed 2026-05-14 | -$8.91M derived: sum of 2 quarters · filed 2026-05-14 | -$11.87M derived: sum of 3 quarters · filed 2026-05-14 | -$19.88M derived: sum of 4 quarters · filed 2026-05-14 | ||||
| 2024-12-31 | -$4.59M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$7.55M derived: sum of 2 quarters · filed 2026-03-25 | -$15.56M derived: sum of 3 quarters · filed 2026-03-25 | -$17.14M 10-K · filed 2026-03-25 | ||||
| 2024-09-30 | -$2.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$10.97M derived: sum of 2 quarters · filed 2025-11-13 | -$12.55M 10-Q · filed 2025-11-13 | -$12.43M derived: sum of 4 quarters · filed 2025-11-13 | ||||
| 2024-06-30 | -$8.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | -$9.59M 10-Q · filed 2025-08-11 | -$9.46M derived: sum of 3 quarters · filed 2025-08-11 | -$10.49M derived: sum of 4 quarters · filed 2025-08-11 | ||||
| 2024-03-31 | -$1.58M 10-Q · filed 2025-05-08 | -$1.46M derived: sum of 2 quarters · filed 2025-05-08 | -$2.48M derived: sum of 3 quarters · filed 2025-05-08 | -$3.34M derived: sum of 4 quarters · filed 2025-05-08 | ||||
| 2023-12-31 | $121.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | -$903.00K derived: sum of 2 quarters · filed 2025-03-24 | -$1.77M derived: sum of 3 quarters · filed 2025-03-24 | -$2.48M 10-K · filed 2025-03-24 | -$7.80M 10-K · filed 2024-03-22 | |||
| 2023-09-30 | -$1.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$1.89M derived: sum of 2 quarters · filed 2024-11-12 | -$2.60M 10-Q · filed 2024-11-12 | -$5.75M 10-Q · filed 2023-11-14 | -$3.92M derived: sum of 4 quarters · filed 2024-11-12 | |||
| 2023-06-30 | -$864.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | -$1.57M 10-Q · filed 2024-08-09 | -$3.88M 10-Q · filed 2023-08-14 | -$2.89M derived: sum of 3 quarters · filed 2024-08-09 | -$4.13M derived: sum of 4 quarters · filed 2024-08-09 | |||
| 2023-03-31 | -$709.00K 10-Q · filed 2024-05-14 | -$1.86M 10-Q · filed 2023-05-12 | -$2.03M derived: sum of 2 quarters · filed 2024-05-14 | -$3.27M derived: sum of 3 quarters · filed 2024-05-14 | -$5.01M derived: sum of 4 quarters · filed 2024-05-14 | |||
| 2022-12-31 | -$1.32M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22 | -$2.56M derived: sum of 2 quarters · filed 2024-03-22 | -$4.30M derived: sum of 3 quarters · filed 2024-03-22 | -$5.94M 10-K · filed 2024-03-22 | ||||
| 2022-09-30 | -$1.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$2.98M derived: sum of 2 quarters · filed 2023-11-14 | -$4.62M 10-Q · filed 2023-11-14 | -$6.26M derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | -$1.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$3.38M 10-Q · filed 2023-08-14 | -$5.03M derived: sum of 3 quarters · filed 2023-08-14 | -$6.91M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | -$1.64M 10-Q · filed 2023-05-12 | -$3.28M derived: sum of 2 quarters · filed 2023-05-12 | -$5.17M derived: sum of 3 quarters · filed 2023-05-12 | -$6.86M derived: sum of 4 quarters · filed 2023-05-12 | ||||
| 2021-12-31 | -$1.65M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$3.53M derived: sum of 2 quarters · filed 2023-03-31 | -$5.22M derived: sum of 3 quarters · filed 2023-03-31 | -$7.86M 10-K · filed 2023-03-31 | ||||
| 2021-09-30 | -$1.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$3.58M derived: sum of 2 quarters · filed 2022-11-10 | -$6.21M 10-Q · filed 2022-11-10 | -$7.83M derived: sum of 4 quarters · filed 2022-11-10 | ||||
| 2021-06-30 | -$1.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | -$4.32M 10-Q · filed 2022-08-12 | -$5.94M derived: sum of 3 quarters · filed 2022-08-12 | -$7.83M derived: sum of 4 quarters · filed 2022-08-12 | ||||
| 2021-03-31 | -$2.63M 10-Q · filed 2022-05-13 | -$4.25M derived: sum of 2 quarters · filed 2022-05-13 | -$6.14M derived: sum of 3 quarters · filed 2022-05-13 | -$8.38M derived: sum of 4 quarters · filed 2022-05-13 | ||||
| 2020-12-31 | -$1.62M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | -$3.51M derived: sum of 2 quarters · filed 2022-03-29 | -$5.75M derived: sum of 3 quarters · filed 2022-03-29 | -$7.82M 10-K · filed 2022-03-29 | ||||
| 2020-09-30 | -$1.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | -$4.13M derived: sum of 2 quarters · filed 2021-11-12 | -$6.20M 10-Q · filed 2021-11-12 | -$8.61M derived: sum of 4 quarters · filed 2021-11-12 | ||||
| 2020-06-30 | -$2.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | -$4.31M 10-Q · filed 2021-08-13 | -$6.72M derived: sum of 3 quarters · filed 2021-08-13 | -$9.09M derived: sum of 4 quarters · filed 2021-08-13 | ||||
| 2020-03-31 | -$2.06M 10-Q · filed 2021-05-17 | -$4.47M derived: sum of 2 quarters · filed 2021-05-17 | -$6.85M derived: sum of 3 quarters · filed 2021-05-17 | -$9.61M derived: sum of 4 quarters · filed 2021-05-17 | ||||
| 2019-12-31 | -$2.41M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | -$4.78M derived: sum of 2 quarters · filed 2021-03-31 | -$7.54M derived: sum of 3 quarters · filed 2021-03-31 | -$10.16M 10-K · filed 2021-03-31 | ||||
| 2019-09-30 | -$2.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | -$5.13M derived: sum of 2 quarters · filed 2020-11-16 | -$7.75M 10-Q · filed 2020-11-16 | -$9.79M derived: sum of 4 quarters · filed 2020-11-16 | ||||
| 2019-06-30 | -$2.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | -$5.38M 10-Q · filed 2020-08-14 | -$5.10M 10-Q · filed 2019-08-14 | -$7.42M derived: sum of 3 quarters · filed 2020-08-14 | -$9.21M derived: sum of 4 quarters · filed 2020-08-14 | |||
| 2019-03-31 | -$2.62M 10-Q · filed 2020-05-14 | -$4.66M derived: sum of 2 quarters · filed 2020-05-14 | -$6.45M derived: sum of 3 quarters · filed 2020-05-14 | -$8.61M derived: sum of 4 quarters · filed 2020-05-14 | ||||
| 2018-12-31 | -$2.05M derived: 10-K/A 12 month − 10-Q 9 month · filed 2020-03-31 | -$3.83M derived: sum of 2 quarters · filed 2020-03-31 | -$5.99M derived: sum of 3 quarters · filed 2020-03-31 | -$8.00M 10-K/A · filed 2020-03-31 | ||||
| 2018-09-30 | -$1.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | -$3.94M derived: sum of 2 quarters · filed 2019-11-14 | -$5.95M 10-Q · filed 2019-11-14 | |||||
| 2018-06-30 | -$2.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | -$4.17M 10-Q · filed 2019-08-14 | ||||||
| 2018-03-31 | -$2.00M 10-Q · filed 2019-05-15 | |||||||
| 2017-12-31 | -$6.29M 10-K · filed 2019-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| TALPHERA, INC. (TLPH) | United States | $0.060B |